During the past decade, Hematology Oncology Consultants, Inc conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hematology Oncology Consultants, Inc" #1 sponsor was "Chiron Corporation" with 2 trials, followed by "GlaxoSmithKline" with 2 trials sponsored, "Novartis" with 2 trials sponsored, "Prologue Research International" with 2 trials sponsored and "Sanofi" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology Oncology Consultants, Inc" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Ortho Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hematology Oncology Consultants, Inc" are "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Lung Cancer" (4 trials), "Breast Neoplasms" (2 trials) and "Lymphoma, Non-Hodgkin" (2 trials). Many other conditions were trialed in "Hematology Oncology Consultants, Inc" in a lesser frequency.

Most popular intervention types in "Hematology Oncology Consultants, Inc" are "Drug" (25 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "oxaliplatin" (4 trials), "fluorouracil" (3 trials), "leucovorin calcium" (3 trials) and "FOLFOX regimen" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hematology Oncology Consultants, Inc" are 20 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hematology Oncology Consultants, Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Hematology Oncology Consultants, Inc, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hematology Oncology Consultants, Inc, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".